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• Statement of the problem
• Objectives of the study





• Why model HIV/ AIDS
• Interaction of the HIV virus and the immune 
system of an infected person
• Why stochastic processes
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Problem statement
• Eradication of the HIV virus is not attainable 
with the current available drugs and now the 
focus is the management and control of the 
virus progression in an infected person.
• The allocation of the limited budget by the 
Government to combat the disease.
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Research Objectives
Main objective
• To develop stochastic models for the study of HIV 
internal viral dynamics and its management.
Specific objectives
• Formulate a model for the Virus – host interaction
• Formulate stochastic Models for the progression of the 
disease
• Formulate a HIV Management Cost (HMC) Model
• Formulate a Cost Benefit Analysis (CBA) Model
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Significance of the study
• Stochastic models for the management of the 
HIV epidemic
– The analysis of the models will show what 
treatment combination is effective at what 
disease state.
– The cost model will help the government and 
donors make informed decisions about resource 
allocation
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Methodology
Framework for stochastic processes
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Methodology  (Cont)
objective 1:  HIV – Host interaction dynamics
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Research Methodology(cont)
HIV virus –host Interaction dynamics
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Rachel (2012)
Possible transitions in HIV - host interactions
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The Master equation for Virus-Host interaction
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The Lagrange Partial Differential Equation 
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Moments of X(t), Y(t) and V(t) from the pgf
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Methodology  (Cont)
objective 2:  HIV virus progression dynamics
Thursday, July 26, 2012 14
HIV  progression dynamics
• We will assume that that the clinical course of 
untreated HIV infection proceeds through five states:
Research Methodology(cont)
State  I:   (VL ≤ 400 cp/ml & CD4 
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< 200x106 cells/ µL);
State  2: (VL ≤ 400 cp/ml &CD4 
> 200x106 cells/ µL);
State  3: (VL > 400 cp/ml &  CD4 
> 200 x106 cells/ µL);
State  4: (VL > 400 cp/ml &CD4 
< 200 x106 cells/ µL);
State  D:  Absorbing state; ( 
death of the patient).
Expected outcomes
• Stochastic model for Virus –host interaction 
• Markov models to describe the disease 
internal progression in an infected person
• Transition probabilities that describe the 
various stages of the disease
• A Disease Management Cost (DMC) model
• Cost Benefit Analysis (CBA) model
• Future Scientific Research
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Thank you
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